Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lomon

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Immunity|September 1, 2019
Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III InterferonsAdriana Forero, Snehal Ozarkar, Hongchuan Li, et al.
Nature Medicine|January 15, 2010
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R Janes, Jose J Limon, Lomon So, et al.
The Journal of Biological Chemistry|January 1, 2013
Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte functionLomon So, Sung Su Yea, Jean S Oak, et al.
The Journal of Experimental Medicine|March 16, 2021
Germline SAMD9L truncation variants trigger global translational repressionEric J Allenspach, Frank Soveg, Laura S Finn, et al.
Nature Medicine|January 16, 2019
Translation control of the immune checkpoint in cancer and its therapeutic targetingYichen Xu, Mauro Poggio, Hyun Yong Jin, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Immunity|September 1, 2019
Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III InterferonsAdriana Forero, Snehal Ozarkar, Hongchuan Li, et al.
Nature Medicine|January 15, 2010
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitorMatthew R Janes, Jose J Limon, Lomon So, et al.
The Journal of Biological Chemistry|January 1, 2013
Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte functionLomon So, Sung Su Yea, Jean S Oak, et al.
The Journal of Experimental Medicine|March 16, 2021
Germline SAMD9L truncation variants trigger global translational repressionEric J Allenspach, Frank Soveg, Laura S Finn, et al.
Nature Medicine|January 16, 2019
Translation control of the immune checkpoint in cancer and its therapeutic targetingYichen Xu, Mauro Poggio, Hyun Yong Jin, et al.
Pageof 5